ArticleScientific reports2025
Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Menopausal Hormone Therapy and Cardiovascular Risk: Current Evidence and Clinical Implications.Medical sciences (Basel, Switzerland) · 2026Review
- Implications of inflammation and sex in lower extremity arterial disease.European journal of clinical investigation · 2026Review
- Trend and burden of ischemic stroke attributable to high body mass index in China from 1990 to 2021, with projection to 2044.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
People with diabetes or prediabetes face a higher risk of cardiovascular events. However, the impact of sex and menopausal hormone therapy on cardiovascular disease (CVD) in these individuals remains unclear. We examined cardiovascular event risk and the association between menopausal hormone therapy and CVD risk in female Koreans with diabetes or prediabetes. We utilized the National Health Insurance Service database from 2009 to 2019. People undergoing hemodialysis or with an eGFR < 15 mL/min/1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.